missy lowery, msc head of integrated marketing ... - nia-west - missy - nia... · innovations in...
TRANSCRIPT
Innovations in Design: NIA-West
1
MissyLowery,MScHeadofIntegratedMarketingCapsugel,nowaLonza company11/13/2017
Prod
uct
Ran
geDosage form selection can help to answer consumer demand
4
Liquid-filled Hard Capsules
Soft Gelatin Capsules SachetHard Capsules
Powder / Multi-particulate Filled Capsules
Osmotic, Matrix, Orally Dissolving Tablets
Key
Se
rvic
es
API Characterization / Pre-formulation Studies
API-in-Capsule / Micro-dosingEvaluations
Commercial Manufacturing
Technology Selection Models / Methodologies
Clinical Trial Material (CTM) Manufacture
CTM Primary / Secondary Packaging & Distribution
Drug Product Intermediate
Specialized Handling (highly potent API, controlled
substances, cold chain, hormones, probiotics, other)
Bioavailability Enhancement Targeted Release Capsule Technologies /
EncapsulationSpecialized Applications
Salt Screening / Selection
Micronization
Spray-Dried Dispersions
Hot-Melt Extrusion
Lipid-Based Formulations
Liquid / Solvent-Based Formulations
Nanotechnologies
• Nano-milling
• Nano-crystals
Enteric / Delayed Release Capsule
Technologies
Multi-particulate Technologies
• Fluid-bed layering
• Extrusion/Spheronization
• Lipid Multiparticulates (LMP)
• Mini-tabs
Fixed Dose Combinations
• Bi/Tri Layer Matrix
• Capsule-in-Capsule
• Multiparticulates
Extended / Controlled Release
• Osmotic / zero order release
• Matrix and MP / 1st order release
Colonic Delivery / Liquid Fill Tech
Gelatin Capsules (Coni-Snap)
Specialty Polymer Capsules
• Vcaps Plus (HPMC)
• PlantCaps and OceanCaps
Enteric Capsules
• DRcaps
• Vcaps Enteric
• enTRinsic DDT
DPI Capsules (inhalation)
Sprinkle Capsules
Encapsulation Technologies
Specialized Clinical Trial Capsules
Taste-Masking Approaches
Pediatric Applications
• MP formulations
• Sprinkle Capsules
Biotherapeutics
• Bio-processing
• Bio-formulations
Inhalation
• SD-based formulations
• DPI capsules
Abuse Deterrent Forms
Licaps® unique liquid-filled capsule delivery
6
• Innovative Liquid Supplement Deliveryü Gelatin, vegetarian and organic capsule options which includes
Non GMO Verified and Clean Label benefitü Filled with liquids, lipids, pastes, and semi-solids
ü Timed release options leveraging polymer choice and combinations
ü Proprietary filling and sealing (fusion) technology
ü Nitrogen bubble helps enhance stability
• Health conscious customersü Combine incompatible ingredients into single doseü Great protection combination depending on
ingredient needs
• Target marketsü Consumer preferring liquid form for faster absorption
ü Unique solution to differentiate performance and consumer identification
DUOCAP® Licaps® Beadlets DUOCAP® with
Beadlets
Liquid Dosage Forms – Gelatin Capsules
7
Functionality:1. Lowoxygenpermeability2. Instantsealing(Lowviscosityrequirement)3. Nitrogenbubblehelpsmaintainstability
Benefits:
• EnhancedprotectionforoxygensensitiveproductsExample:Ubiquinol – veryunstablewhenexposedtoair
• EfficientodorandaftertasteprotectionExample:KrillOil– Eliminatesodor
• IncreasecapabilitiesversussoftgelsHighsolidload,lowerviscosity,toleranttoheat
Liquid Solution in a Capsule
• Encapsulation of a pre-solubilized ingredient which is soluble in water or oil
• Designed for improved rate of dissolution for fast release and better bioavailability
• Example uses for this form: üL-Arginine- creation of a free-flowing solution
allows for a higher concentration of active ingredient
üL-Carnitine- liquid form can contain pure L-Carnitine rather than the less soluble salts
L-Arginineinsuspension
L-Argininesolubilized
Micronized Liquid Suspension in a Capsule
• Encapsulation of an insoluble ingredient that has been micronized to a particle size less than 10 microns üSuspended in a lipid or solvent fillüParticles flow freely and are barely
detectable
• Also designed for improved rate of dissolution and better bioavailability
Beadlets in a Liquid-filled Capsule
• Multi component, multi-sized beadlets are suspended in a liquid-fillüLiquid can also contain active ingredients
• Designed to offer flexibility in multiple release rates (immediate, delayed)
• Good for combining incompatible actives or allowing an active to by-pass gastric acids
– Beads allow for targeting and varying levels of controlled release– Can combine fast acting liquid with slow release ingredients
Powder-filled Inner Capsule in a Liquid-filled Outer Capsule
• Size 3 or 4 HPMC capsule filled with a moisture sensitive compound and suspended in a liquid filled HPMC capsule
• Benefits of the MDS/Capsule-in-a-Capsule:ü Designed for a delayed release: inner capsule will
rupture 1-2 hours after ingestionü Protects moisture sensitive compounds
– Water activity in the liquid fill is lower than that of the inner capsule contents, drawing moisture away from the active
– HPMC capsule creates a protective barrier from the outside environment
• Ideal for moisture sensitive compounds such as probiotics and enzymes
§ Studyconfirmedstabilityofprobiotics inDUOCAP®capsule§ CapsugelrecommendationtouseGlycerolasliquidfillinoutsidecapsule
for Probiotics –DUOCAP capsule Stability Study Results
13*recentregistrationchangeSource:CapsugelLabResearch
DUOCAP® Dissolution Case Study
14
• Capsule design eliminates the need for any coatings
• Slower dissolution of the inner capsule
0
20
40
60
80
100
0 1 2 3 4 5 6 7 8
PERC
ENTA
GEDISSOLVED
TIME(HOURS)
Outer
Inner
Gelatin
Dissolution testing was performed using an acetaminophen marker in the outer capsule and a caffeine marker in the inner capsule; medium was USP simulated gastric fluid for the first two hours and then changed to USP simulated intestinal fluid
Beadlet-filled Capsule in a Liquid-filled Capsule
• Combines benefits of a capsule in a capsule with the controlled release properties of beadlets for added extended release
• Designed to offer multiple release rates-beadlets in an inner HPMC capsule can release over 6 to 8 hours
• Good uses for this delivery system would be melatonin or caffeine. Immediate release for rest or energy that will keep working over a period of time
• Caffeine• Theacrine
Timed release of ingredients is important to consumer experience during pre-workout, during workout and recovery
16
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0 100 200 300 400 500
%dissolved(LC)
SamplingTime(min)
0.020.040.060.080.0100.0
0 100 200 300 400 500
%dissolved(LC)
SamplingTime(min)
CAFFEINECONTROLLED-RELEASECASESTUDY
Providing protection for acid-sensitive ingredients
17
• Unlike other consumer health products, enzymes and probiotics are damaged when exposed to harsh stomach conditions and must be maintained as such in order to be efficient.
• A number of sports nutrition ingredients benefit from the delay in release as well
• Humidity
• Temperature
• Acidstomachcondition
DRcaps™ capsules - Proven Targeted Release
18
KeyStudyFindings• DRcapscapsulesdisplayeddelayedreleaseproperties
• Disintegrationstartedapproximately45minuteslaterthanatypicalimmediatereleasecapsuleofabout5minutes
• Forthemajorityofsubjects, completereleasetookplaceintheintestine
• Completereleaseoccurred20minutesaftertheonsetofrelease
• DRcapscapsulessignificantly reducedopportunity fornutritionalingredientdegradationcomparedwithstandardimmediatereleasecapsules
DRcaps™CapsuleHumanClinicalStudy
Capsules Sprinkle Capsules
SachetsRTD Powder
Beverage
Lipid Multi-particulate (LMP) dosage form versatility
19
LMPs
LMPApplications
Canimprovetheperformanceofnutritionalactivesintwodistinctcategories:
Curcuminü Avoidclumping ofloose ingredientsandlowelectrostatic
attractionü Consistent releaseforupto6hours(no spikes)ü Useforcombination ingredients
Orally DisintegratingTablets (ODTs)Energy Drinks
Case Study: Improving the delayed release of a mood enhancing product
20
• Dissolution Study conducted on LMP filled into DRcaps™ capsules• Controls: LMP filled into gelatin capsule; 2 commercial enteric coated tablets• Dissolution was tested in two stage media: 0.1N HCl for two hours followed by pH 6.8
phosphate buffer• USP Apparatus 1, 100 rpm, 37°C
0
20
40
60
80
100
120
0 2 4 6 8 10 12 14
%Released
Time (Hrs)
LMPinDRCap LMPinHardGelatinCap CommercialProductA CommercialProductB
LMP in DRcaps capsules release about 10% active at 2 hr
BCAA sustained-release LMP
• BCAAs (L-Leucine, L-Isoleucine & L-Valine) comprise 35% of the amino acids that build muscle. L-Leucine is a regulator that activates protein synthesis through the mTOR (mammalian target of rapamycin)
• Some BCAA products are cheap, synthetic versions that are not water soluble
• BCAAs also have been shown to degrade after being subjected to stomach acids
• BCAAs are bitter in taste and have an unpleasant smell
SustainedRelease
TasteMasking
BioavailabilityEnhancement
Min.4hsustained releaseForprotein shakes with (fastand)slowreleaseBCAA
Neutraltasteand smellLess sugar and flavor needed
Improved stability instomach acids
Less dosage needed
21